Comparison of aprepitant versus desloratadine for EGFR-TKI-induced pruritus: A randomized phase 2 clinical trial.
Ting ZhouYaxiong ZhangYuxiang MaWenjuan MaXuan WuLu HuangWeineng FengHuaqiang ZhouJiaqing LiuHongyun ZhaoLi ZhangYunpeng YangYan HuangPublished in: Cancer (2022)
ClinicalTrials.gov Identifier: NCT02646020.